Related Experiment Videos
Simvastatin and disease stabilization in normal tension glaucoma: a cohort study
Dexter Y L Leung1, Felix C H Li, Yolanda Y Y Kwong
1Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Hong Kong Special Administrative Region, The People's Republic of China. dexleung@alumni.cuhk.net
Simvastatin use may help stabilize visual fields in normal tension glaucoma (NTG) patients. This finding suggests a potential protective effect, warranting further investigation in larger trials.
Area of Science:
- Ophthalmology
- Neurology
- Pharmacology
Background:
- Normal tension glaucoma (NTG) is a progressive optic neuropathy.
- Visual field (VF) loss is a primary indicator of glaucoma progression.
- Identifying factors that stabilize VF is crucial for managing NTG.
Purpose of the Study:
- To determine if simvastatin use is associated with visual field stabilization in normal tension glaucoma (NTG) patients.
- To explore potential neuroprotective effects of statins in glaucoma.
Main Methods:
- Prospective cohort study involving 256 Chinese subjects with NTG.
- 36-month follow-up with 4-month intervals to assess VF progression using Anderson's criteria.
- Multivariate analysis to identify clinical parameters associated with progression, including simvastatin use.
Main Results:
- Simvastatin use was associated with a significantly lower rate of VF progression (P = 0.030).
- Logistic regression indicated simvastatin conferred a protective effect (RR 0.36; 95% CI, 0.14-0.91).
- History of disc hemorrhage, cerebrovascular accidents, and older age were significant risk factors for VF progression.
Conclusions:
- Simvastatin use may be linked to visual field stabilization in NTG patients.
- Further large-scale randomized controlled trials are recommended.
- Cost-effectiveness analyses are suggested to evaluate the clinical utility of simvastatin in NTG management.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Hypertension III: Clinical Manifestations and Diagnostic Studies
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Diabetic Retinopathy